AstraZeneca signs license agreement with China’s CSPC worth up to $2bn
October 09, 2024 UK pharmaceutical giant AstraZeneca has entered into an exclusive license agreement with China’s CSPC Pharmaceutical Group (CSPC) to advance the development...